Literature DB >> 11207245

Differential regulation of human blood dendritic cell subsets by IFNs.

T Ito1, R Amakawa, M Inaba, S Ikehara, K Inaba, S Fukuhara.   

Abstract

Based on the relative expression of CD11c and CD1a, we previously identified subsets of dendritic cells (DCs) or DC precursors in human peripheral blood. A CD1a(+)/CD11c(+) population (CD11c(+) DCs), also called myeloid DCs, is an immediate precursor of Langerhans cells, whereas a CD1a(-)/CD11c(-) population (CD11c(-) DCs), sometimes called lymphoid DCs but better known as plasmacytoid DCs, is composed of type I IFN (IFN-alpha beta)-producing cells. Here, we investigate the effects of IFN-alpha beta and IFN-gamma as well as other cytokines on CD11c(+) and CD11c(-) DC subsets, directly isolated from the peripheral blood, instead of in vitro-generated DCs. IFN-gamma and IFN-alpha, rather than GM-CSF, were the most potent cytokines for enhancing the maturation of CD11c(+) DCs. Incubation of CD11c(+) DCs with IFN-gamma also resulted in increased IL-12 production, and this IL-12 allowed DCs to increase Th1 responses by alloreactive T cells. In contrast, IFN-alpha did not induce IL-12 but, rather, augmented IL-10 production. IFN-alpha-primed matured CD11c(+) DCs induced IL-10-producing regulatory T cells; however, this process was independent of the DC-derived IL-10. On the other hand, IFN-alpha by itself neither matured CD11c(-) DCs nor altered the polarization of responding T cells, although this cytokine was a potent survival factor for CD11c(-) DCs. Unlike IFN-alpha, IL-3 was a potent survival factor and induced the maturation of CD11c(-) DCs. The IL-3-primed CD11c(-) DCs activated T cells to produce IL-10, IFN-gamma, and IL-4. Thus, CD11c(+) and CD11c(-) DC subsets play distinct roles in the cytokine network, especially their responses to IFNs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207245     DOI: 10.4049/jimmunol.166.5.2961

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  90 in total

1.  Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets.

Authors:  Kenichirou Tajima; Ryuichi Amakawa; Tomoki Ito; Michihiko Miyaji; Masashi Takebayashi; Shirou Fukuhara
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Study on immune function of dendritic cells in patients with esophageal carcinoma.

Authors:  Shen-Ren Chen; Yi-Ping Luo; Jin-Kun Zhang; Wei Yang; Zhi-Chao Zhen; Lin-Xin Chen; Wei Zhang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

3.  The Effects of Dendritic Cell Hypersensitivity on Persistent Viral Infection.

Authors:  Jennifer S Tsau; Xin Huang; Chen-Yen Lai; Stephen M Hedrick
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

4.  Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.

Authors:  Matthieu Perreau; Franck Mennechet; Nicolas Serratrice; Joel N Glasgow; David T Curiel; Harald Wodrich; Eric J Kremer
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 5.  The role of type I interferon production by dendritic cells in host defense.

Authors:  P Fitzgerald-Bocarsly; D Feng
Journal:  Biochimie       Date:  2007-05-08       Impact factor: 4.079

6.  HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype.

Authors:  Simona Fiorentini; Elena Riboldi; Fabio Facchetti; Manuela Avolio; Marco Fabbri; Giorgio Tosti; Pablo D Becker; Carlos A Guzman; Silvano Sozzani; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-29       Impact factor: 11.205

Review 7.  Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history.

Authors:  Patricia Fitzgerald-Bocarsly; Jihong Dai; Sukhwinder Singh
Journal:  Cytokine Growth Factor Rev       Date:  2008-01-11       Impact factor: 7.638

Review 8.  Functional diversity and plasticity of human dendritic cell subsets.

Authors:  Tomoki Ito; Yong-Jun Liu; Norimitsu Kadowaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

9.  Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.

Authors:  Hiroyuki Tada; Setsuya Aiba; Ken-Ichiro Shibata; Toshiaki Ohteki; Haruhiko Takada
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

10.  Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.

Authors:  A Tamir; W J Jordan; M Ritter; N Habib; R I Lechler; G R Foster; G Lombardi
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.